| Patients | n = 112 |
| Age (yr, mean ± SD) | 61.2 ± 16.9 |
| Male | 56 (50.0%) |
| Multiple CBD stones | 46 (41.1%) |
| Diameter of CBD (mm) | 13.49 ± 1.71 |
| Gallbladder stones | 64 (57.1%) |
| Periampullary diverticulum | 42 (37.5%) |
| Total bilirubin (µmol/L) | 60.45 (19.35 - 111.55) |
| Comorbidities |
|
| Coronary disease | 7 (6.3%) |
| Hypertension | 14 (12.5%) |
| Diabetes | 12 (10.7%) |
| Liver cirrhosis | 9 (8.0%) |
| Portal hypertension | 6 (5.4%) |
| Procedure time, min (mean ± SD) | 63.43 ± 15.47 |
| Procedure-related adverse events |
|
| Cholangitis | 9 (8.0%) |
| Oozing | 4 (3.6%) |
| PEP | 12 (10.7%) |
| Cholecystitis | 0 |
| Perforation | 0 |
| Death | 0 |